libr medicar coverag kick
abbott announc morn medicar coverag libr fgm come
heel replac claim libr sadli enough believ
develop undercut competit advantag contend
addit headlin risk vis-a-vi guardian connect cgm approv
pipelin much like technolog believ stock bound
pressur next month move under-perform
said note date launch time suck
big time howev fundament analysi core technolog
remain best class sensor compani excel product
cage match pure accuraci contend would
win hand howev rule game chang libr
replac claim medicar coverag
tempt argu stori base merit accuraci
mard rate argu libr fgm good enough larg
swath patient especi given almost price
up-front cost ye provid real-tim continu glucos monitor
one make claim libr fgm especi replac claim
probabl better posit entic first-tim patient mdi
price elast demand import mayb time patient get
concern accuraci move back worri
new patient start henc growth rate could risk
written see could maintain margin
profil new competit environ long-term price eros new risk
even introduct verili product
time logic dictat verili cgm would need price significantli
lower order compet effect bar clinic event libr
give us one good reason guardian connect also garner
given abbott vast resourc experi deal medicar patient
argu expect growth sector
ratchet significantli might well great print
problem realli futur outlook cloudi natur necessit
lower multipl stock
lower medicar compon growth outlook
necessit lower pt under-perform rate
statement oper
number mm
good
prdt dev
sg
page
leader stand-alone continu glucos monitor system
lower pt repres forward p/
risk achiev price target
libr gain reimburs cgm
libr gain greater share new patient
suraj kalia certifi view express report accur reflect person view
subject compani secur part compens directli
indirectli relat specif recommend view express report
